Asterias Biotherapeutics (AST) Trades at $3.35 After Triangle; Profile of 2 Analysts Covering Telecom Italia SpA (ADR) (TI)

June 21, 2017 - By Peter Erickson

Among 11 analysts covering Telecom Italia (NYSE:TI), 2 have Buy rating, 2 Sell and 7 Hold. Therefore 18% are positive. Telecom Italia had 14 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, December 12 by Gabelli. The firm has “Neutral” rating given on Monday, November 16 by BNP Paribas. The firm has “Hold” rating given on Thursday, July 30 by Berenberg. The company was upgraded on Monday, October 17 by Barclays Capital. The stock has “Neutral” rating by Citigroup on Thursday, December 1. The company was upgraded on Thursday, September 22 by Macquarie Research. The firm earned “Sell” rating on Thursday, September 3 by Zacks. Barclays Capital downgraded Telecom Italia SpA (ADR) (NYSE:TI) on Tuesday, October 6 to “Underweight” rating. Barclays Capital downgraded the shares of TI in report on Monday, October 12 to “Underweight” rating. JP Morgan downgraded the stock to “Neutral” rating in Wednesday, July 6 report. See Telecom Italia SpA (ADR) (NYSE:TI) latest ratings:

Asterias Biotherapeutics Inc (AST) formed triangle with $3.62 target or 8.00% above today’s $3.35 share price. Asterias Biotherapeutics Inc (AST) has $175.35M valuation. The stock decreased 1.47% or $0.05 during the last trading session, reaching $3.35. About shares traded. Asterias Biotherapeutics Inc (NYSEMKT:AST) has risen 4.43% since June 21, 2016 and is uptrending. It has underperformed by 12.27% the S&P500.

Among 3 analysts covering Asterias Biotherapeutics (NYSEMKT:AST), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Asterias Biotherapeutics had 5 analyst reports since August 11, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, August 11 by MLV. The firm earned “Buy” rating on Monday, May 23 by Chardan Capital Markets. As per Thursday, November 19, the company rating was initiated by FBR Capital. As per Thursday, September 3, the company rating was upgraded by Zacks. The stock of Asterias Biotherapeutics Inc (NYSEMKT:AST) earned “Outperform” rating by FBR Capital on Tuesday, March 7.

The stock decreased 0.64% or $0.06 on June 20, reaching $9.29. About shares traded. Telecom Italia SpA (ADR) (NYSE:TI) has risen 7.21% since June 21, 2016 and is uptrending. It has underperformed by 9.49% the S&P500.

Telecom Italia S.p.A. operates fixed voice and data infrastructure in Italy, and provides mobile network platforms. The company has market cap of $18.34 billion. The Firm focuses on various areas of digital services, including Enriched Communication, Trusted Digital Life, Business Life, Indoor Life, Mobile Open Life and Digital Entertainment. It has a 11.4 P/E ratio. The Company’s divisions include Consumer, Business, National Wholesale and Other.